SEC 13F Intelligence

Managers / Q2 2023 · view latest →

Tyrus Capital S.A.M.

CIK 0001543065 · 9 AVENUE J.F. KENNEDY, MONACO, O9, MC 98000 · 377 9999 5030

Reported Value
$14M
Q2 2023
Positions
28
Filings on Record
8
2019–present window
Filed
Aug 11, 2023
original filing

Summary

Tyrus Capital S.a.m. reported $14M in U.S.-listed holdings across 28 positions for Q2 2023.

The portfolio is heavily concentrated: AVIR alone accounts for 33.1% of reported value.

Compared with Q1 2023, the fund opened 2 new positions and exited 6.

Portfolio Metrics

Turnover
+5.4%
vs prior filed quarter
Top-10 Concentration
+97.8%
share of reported value
Largest Position
+33.1%
Atea Pharmaceuticals
New / Exited
2 / 6
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $5MQ4 ’18Q1 ’19: $2MQ1 ’19Q2 ’19: $0Q2 ’19Q3 ’19: $1MQ3 ’19Q4 ’22: $46MQ4 ’22Q1 ’23: $17MQ1 ’23Q2 ’23: $14MQ2 ’23Q3 ’23: $11MQ3 ’23filingsflow.com

Portfolio Composition

By security type
Other: 66.3%Common Stock: 33.1%Equity WRT: 0.5%
  • Other · 66.3% · $9M
  • Common Stock · 33.1% · $5M
  • Equity WRT · 0.5% · $77,548

Quarter-over-Quarter Changes full breakdown →

vs Q1 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
GOLDEN FALCON ACQUISITION CONEW+425.0K425.0K+$55,250$55,250
TARGET GLOBAL ACQUISI I CORPNEW+41.7K41.7K+$3,333$3,333
TARGET GLOBAL ACQUISI I CORPSOLD OUT−125.0K0−$1M$0
MOTIVE CAPITAL CORP IISOLD OUT−92.4K0−$964,006$0
JUPITER ACQUISITION CORPSOLD OUT−75.0K0−$757,500$0
CRESCERA CAP ACQUISITION CORSOLD OUT−50.0K0−$523,000$0
MOTIVE CAPITAL CORP IISOLD OUT−30.8K0−$4,832$0
FORBION EUROPEAN ACQUSTN CORSOLD OUT−16.7K0−$2,335$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2023

21 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1AVIRATEA PHARMACEUTICALS INChistory →COM33.11%$5M1.26M
2GLOBAL PARTNER ACQISTN CORPCL A SHS · *W EXP 01/14/20214.90%$2M233.3K
3DHC ACQUISITION CORPCLASS A ORD SHS · *W EXP 02/25/20210.84%$2M200.0K
4ALTIMAR ACQUISITION CORP IIISHS CL A9.94%$1M137.8K
5L CATTERTON ASIA ACQUISITIONCLASS A ORD SHS · *W EXP 03/08/2027.46%$1M133.3K
6KERNEL GROUP HOLDINGS INCCL A SHS · *W EXP 02/02/2026.67%$949,014135.0K
7FORBION EUROPEAN ACQUSTN CORCLASS A ORD SHS3.77%$536,50050.0K
8ARES ACQUISITION CORPORATIONCOM CL A · *W EXP 02/02/2023.77%$536,50060.0K
9TWIN RIDGE CAPITAL ACQUIS COSHS CL A · *W EXP 03/07/2023.77%$535,91266.7K
10DISRUPTIVE ACQUISITION CORPCLASS A ORD SHS · *W EXP 03/06/2023.61%$513,91766.7K
11OCULIS HOLDING AG*W EXP 03/06/2021.03%$146,665133.3K
12RUMBWRUMBLE INC*W EXP 09/16/2020.41%$57,75027.5K
13GOLDEN FALCON ACQUISITION CO*W EXP 11/04/2020.39%$55,250425.0K
14WALDENCAST PLC*W EXP 07/27/2020.15%$21,62533.3K
15BZFDWBUZZFEED INC*W EXP 12/03/2020.07%$10,000166.7K
16PIIIWP3 HEALTH PARTNERS INC*W EXP 11/19/2020.04%$6,13125.5K
17BBAI/WSBIGBEAR AI HLDGS INC*W EXP 12/08/2020.03%$3,66716.7K
18TARGET GLOBAL ACQUISI I CORPCLASS A ORD SHS0.02%$3,33341.7K
19THUNDER BRIDGE CAP PRTNRS II*W EXP 02/01/2020.01%$1,28810.0K
20CRESCERA CAP ACQUISITION COR*W EXP 11/18/2020.01%$1,21325.0K
21JUPITER ACQUISITION CORP*W EXP 08/17/2020.01%$76137.5K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2023$11M27Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$14M28Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$17M32May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$46M45Feb 10, 202313F-HRchanges · EDGAR ↗
Q3 2019$1M1Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$01Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$2M2May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$5M2Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.